Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies - Takeaways - MDSpire

Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies

  • By

  • Hu Chen

  • Shuai Li

  • Qiuyu Yang

  • Fangzheng Zhou

  • April 23, 2026

  • 0 min

Share

  • 1

    The incidence of brain metastases is rising due to improved cancer survival rates and advancements in diagnostic imaging.

  • 2

    Stereotactic radiotherapy (SRT) is favored for its precision, rapid dose fall-off, and ability to preserve neurocognitive function.

  • 3

    Recent studies indicate that SRT combined with systemic therapies enhances intracranial control without improving overall survival.

  • 4

    Histological type significantly influences treatment outcomes, necessitating individualized approaches to SRT based on tumor biology.

  • 5

    Ongoing research is essential to optimize SRT regimens and explore new indications, including treatment for multiple brain metastases.

Original Source(s)

Stereotactic Radiotherapy for Brain Metastases: A Detailed Overview of Indications, Dose Fractionation, Technological Advances, and Emerging Combination Therapies

  • by Hu Chen, Shuai Li, Qiuyu Yang, Fangzheng Zhou

  • April 23, 2026

Related Content

Immune biomarker landscape and fusion partner–phenotype associations in thoracic and head-and-neck NUT carcinoma

The role of NAD+ metabolic reprogramming in colorectal cancer chemoresistance: mechanistic insights, clinical translation challenges and opportunities

Emerging applications of artificial intelligence for risk stratification in head and neck cancer: a scoping review